Novo Nordisk A/S is asking for more time to answer questions from US Senator Bernie Sanders on the prices of Ozempic and ...
Sen. Bernie Sanders, chair of the Senate Health, Education, Labor and Pensions Committee, has demanded to know why Americans ...
Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
Tencent (OTCMKTS: TCEHY) is one of China’s biggest companies, yet it remains relatively unknown in the West. You may have heard its name, but many overlook the sheer size and outreach this behemoth ...
Building on the continued momentum behind its GLP-1 drugs, the pharma company’s parent company, Novo Holdings, announced a ...
Stock Market News, Stock Advice & Trading Tips To paraphrase Rudyard Kipling, the secret to success in the stock market is to ...
One of the hottest areas in the pharmaceutical space right now is weight loss. Glucagon-like peptide-1 (GLP-1) medications ...
The two companies, as well as third-party manufacturers, are building huge new facilities to make the ingredients needed for ...
Now, the Federal Trade Commission and its chair, Lina Khan, have voted to ban non-competes citing that the agreements ...
Senator Berne Sanders is launching an investigation into the "outrageously high prices" Novo Nordisk charges for the drugs.
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
But it could wind up costing Medicare nearly $ ... steep increases in spending on GLP-1 drugs. It shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million ...